Sunshine Biopharma
(NASDAQ) SBFM
Sunshine Biopharma Financials at a Glance
Market Cap
$5.03M
Revenue (TTM)
$35.49M
Net Income (TTM)
-$6.04M
EPS (TTM)
-$13.02
P/E Ratio
-0.18
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$2.28
Volume
119,502.643
Open
$2.34
Price
$2.28
Volume
119,502.643
Open
$2.34
Previous Close
$2.22
Daily Range
$2.22 - $2.45
52-Week Range
$2.01 - $24.30
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$2.28
Volume
119,502.643
Open
$2.34
Previous Close
$2.22
Daily Range
$2.22 - $2.45
52-Week Range
$2.01 - $24.30
Estimated Earnings Date
Aug 5, 2026
SBFM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sunshine Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
50
CEO
Steve N. Slilaty, PhD
Website
www.sunshinebiopharma.comHeadquarters
Pointe-Claire, QC H9R 0A5, CA
SBFM Financials
Key Financial Metrics (TTM)
Gross Margin
32%
Operating Margin
-13%
Net Income Margin
-17%
Return on Equity
-27%
Return on Capital
-21%
Return on Assets
-22%
Earnings Yield
-5.56%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.03M
Shares Outstanding
2.12M
Volume
119.50K
Avg. Volume
1.55M
Financials (TTM)
Gross Profit
$11.92M
Operating Income
-$4.48M
EBITDA
-$5.62M
Operating Cash Flow
-$5.33M
Capital Expenditure
-$174.49K
Free Cash Flow
-$5.51M
Cash & ST Invst.
$9.12M
Total Debt
$812.42K
Sunshine Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.09M
-9.1%
Gross Profit
$2.10M
-22.9%
Gross Margin
26.01%
N/A
Market Cap
$5.03M
N/A
Market Cap/Employee
$96.79K
N/A
Employees
52
N/A
Net Income
-$1.24M
-5.4%
EBITDA
-$1.17M
-1.0%
Quarterly Fundamentals
Total Cash
$6.91M
-15.6%
Total Debt
$744.84K
-20.4%
Accounts Receivable
$4.01M
+16.4%
Inventory
$13.17M
+11.1%
Long Term Debt
$535.61K
-25.8%
Short Term Debt
$209.23K
-2.2%
Return on Assets
-21.62%
N/A
Return on Invested Capital
-20.76%
N/A
Free Cash Flow
-$2.08M
-7.9%
Operating Cash Flow
-$2.07M
-20.9%